KMD Bioscience Aptamer Screening Service-Aptamer Screening for Small Molecule Targets
Info Center
Home » aptamer screening service » KMD Bioscience Aptamer Screening Service-Aptamer Screening for Small Molecule Targets

KMD Bioscience Aptamer Screening Service-Aptamer Screening for Small Molecule Targets

Date：2025-12-20

Core Challenge with Small Molecules

Small molecules (e.g., drugs, toxins, metabolites, <1000 Da) lack the large, multi-epitope surfaces of proteins. This makes traditional selection methods difficult because:

  1. Immobilization: Hard to attach to a solid phase without masking the target area.

  2. Limited Binding Interfaces: Offer fewer points for oligonucleotide interaction.

  3. Low Signal-to-Noise: Distinguishing specific binders from non-specific binders is tougher.

Key Aptamer Screening Techniques Used for Small Molecules

KMD Bioscience likely employs a combination of these advanced SELEX (Systematic Evolution of Ligands by EXponential Enrichment) variants:

1. Capture-SELEX (The most common for small molecules)

  • Principle: Instead of immobilizing the small molecule, a DNA library with a fixed primer sequence is immobilized on beads. The small molecule is free in solution.

  • Process: The small molecule is introduced. Sequences that bind to it undergo a conformational change, freeing them from the bead into the solution. These eluted sequences are then amplified.

  • Advantage: The target remains in its native, unmodified state, preserving its structure and function. Ideal for targets that are difficult to tag or immobilize.

2. Graphene Oxide-SELEX (GO-SELEX)

  • Principle: Utilizes graphene oxide’s ability to adsorb single-stranded DNA (ssDNA) non-specifically via π-π stacking.

  • Process: The ssDNA library is incubated with GO. Unbound sequences are discarded. The small molecule target is then added. Aptamers with affinity for the target will bind to it and be released from the GO surface. These are collected and amplified.

  • Advantage: No need to modify either the target or the library. Simple, effective, and excellent for counter-selection steps to remove non-specific binders.

3. Magnetic Bead-Based SELEX (with conjugated targets)

  • Principle: The small molecule is chemically conjugated to a larger carrier (like BSA or a hapten) or directly to a tag (biotin), which is then immobilized on magnetic beads.

  • Process: The DNA library is incubated with the target-conjugated beads. Bound sequences are separated magnetically, eluted, and amplified.

  • Challenge: Careful design is needed to ensure the conjugation chemistry doesn’t block the critical binding site of the small molecule. Counter-selection against the carrier/bead alone is essential.

4. Capillary Electrophoresis-SELEX (CE-SELEX)

  • Principle: Leverages the high-resolution separation power of capillary electrophoresis based on the mobility shift that occurs when an aptamer binds to its target.

  • Process: The library is mixed with the free small molecule and injected into a capillary. The aptamer-target complexes separate from unbound sequences due to differences in charge/size. The complexed fraction is collected.

  • Advantage: Extremely efficient, often requiring far fewer rounds (2-5) than traditional SELEX. Works with targets in solution, no immobilization needed. Excellent for achieving very high-affinity aptamers.

5. Toggle-SELEX (for cross-species reactivity)

  • Principle: While not exclusive to small molecules, it can be used if the goal is to get an aptamer that recognizes a small molecule across different formats or similar analogues. Selection rounds are “toggled” between the pure small molecule and a related target (e.g., a protein-drug complex).

  • Advantage: Can increase the specificity range or generate aptamers that recognize a common epitope.

Typical Workflow at a Service Provider like KMD Bioscience

  1. Consultation & Design: They work with you to define the small molecule target, desired affinity (Kd), specificity (against closely related analogs), and application (diagnostic sensor, therapeutic inhibitor, purification tool).

  2. Library & Strategy Selection: Choice of a random ssDNA or RNA library (typically 40-80 nt random region). Decision on the most appropriate SELEX technique (e.g., Capture-SELEX for a hydrophobic drug).

  3. SELEX Rounds (8-15 rounds typical):

    • Positive Selection: Incubation of the library with the target under optimized buffer conditions (pH, ions, Mg²⁺).

    • Stringency Washing: Increasing wash stringency over rounds to select for the strongest binders.

    • Counter-Selection: Critical step. The pool is passed over an inert surface or a related molecule to subtract sequences that bind to anything other than the desired epitope of the small molecule.

    • Elution & Amplification: Recovery of bound sequences (by heat, denaturation, or competitive elution) and PCR amplification (RT-PCR for RNA). For ssDNA generation, a method like strand separation or biotin-streptavidin purification is used.

  4. Monitoring: Progress is tracked using quantitative PCR (to monitor enrichment) or sometimes fluorescence-based assays.

  5. Next-Generation Sequencing (NGS) & Bioinformatics:

    • The final enriched pool is sequenced via NGS.

    • Bioinformatic analysis identifies families of related sequences, consensus motifs, and predicts secondary structures.

    • Candidate aptamers (e.g., top 10-20) are chosen for synthesis.

  6. Characterization & Validation:

    • Affinity Measurement: Surface Plasmon Resonance (SPR) or Bio-Layer Interferometry (BLI) are gold standards for determining the dissociation constant (Kd).

    • Specificity Testing: Testing against structural analogs to confirm cross-reactivity or desired specificity.

    • Functional Assays: Testing in the intended application format (e.g., colorimetric assay, inhibition assay).

Unique Selling Points a Company Like KMD Bioscience Might Highlight

  • Integrated Platform: From selection (SELEX) to sequencing (NGS) to synthesis and characterization (SPR/BLI) all in-house.

  • Proprietary Modified Nucleotides: Use of chemically modified libraries (e.g., 2′-F, 2′-O-methyl pyrimidines) to enhance nuclease resistance for in vivo applications.

  • High-Throughput Screening: Ability to screen dozens of candidate aptamers in parallel.

  • Customization: Tailoring buffer conditions and selection pressure to your exact needs.

Key Questions to Ask a Service Provider

If you are considering such a service, ask:

  1. What is your preferred immobilization/conjugation strategy for my specific small molecule?

  2. How do you design and implement counter-selection to ensure specificity?

  3. What is your standard method for affinity and specificity validation?

  4. Can you provide a timeline and cost estimate for the entire project, including the delivery of characterized aptamer sequences?

  5. Do you offer truncation and optimization services post-discovery to create a minimal, high-activity aptamer?

In summary, screening aptamers for small molecules requires specialized techniques like Capture-SELEX or CE-SELEX to overcome immobilization challenges. A full-service provider like KMD Bioscience would combine these advanced selection methods with state-of-the-art NGS and biophysical analysis to deliver high-affinity, specific aptamers for your target.